Clinical Trials
3 trialsNCT06120140 2026-06-05
COCOON
Janssen Research & Development, LLC
Phase 2 Active not recruiting
NCT05741164 2026-06-04
Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
Emory University
Phase 2 Recruiting
NCT02104011 2026-05-19
STBETA
University Hospital, Bordeaux
Phase 2 Completed